Clinical Trials Browser

Neoplasm Metastasis × pembrolizumab × Endocrine × Clear all

NCT02721732 2026-01-29

Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic

Adrenal Cortex Neoplasms, Carcinoma, Renal Cell, Neoplasm Metastasis, Neoplasms, Unknown Primary, Paraganglioma, Penile Neoplasms, Pheochromocytoma, Carcinoma, Small Cell, Vascular Neoplasms

NCT02939651 2021-03-09

A Study of Pembrolizumab in Patients With Neuroendocrine Tumors

Phase 2 Completed

21 enrolled 10 charts

EndocrineNET

Neoplasm Metastasis, Neuroendocrine Tumors